<DOC>
	<DOCNO>NCT01760421</DOCNO>
	<brief_summary>Hashimoto 's thyroiditis autoimmune thyroid disease , induce chronic inflammation thyroid gland destroy thyroid tissue . Hydroxychloroquine use disease modify anti-rheumatic drug ( DMARD ) treatment several autoimmune disease , systemic lupus erythematosus ( SLE ) , rheumatoid arthritis ( RA ) one century . The purpose study evaluate whether hydroxychloroquine effective treatment Hashimoto 's thyroiditis .</brief_summary>
	<brief_title>The Effect Hydroxychloroquine Treatment Hashimoto 's Thyroiditis</brief_title>
	<detailed_description>Hashimoto 's thyroiditis autoimmune thyroid disease , disease progress , thyroid function finally decline hypothyroidism . There medical treatment recommend patient Hashimoto 's thyroiditis , currently euthyroid state . Levothyroxine replacement therapy start patient become hypothyroid state . Hashimoto 's thyroiditis T-cell mediate autoimmune thyroid disease . The major auto-antigens include thyroid peroxidase ( TPO ) thyroglobulin . Anti-TPO antibody induce antibody-dependent cell-mediated cytotoxicity ( ADCC ) cause destruction thyroid tissue . Antimalarial agent like hydroxychloroquine several pharmacologic effect may involve treatment rheumatic disease , role know . These include interaction sulphydryl group , interference enzyme activity ( include phospholipase , nicotinamide adenine dinucleotide hydrogen-cytochrome C reductase , cholinesterase , proteases hydrolases ) , DNA binding , stabilisation lysosome membrane , inhibition prostaglandin formation , inhibition polymorphonuclear cell chemotaxis phagocytosis . This study investigate treatment effect hydroxychloroquine autoantibody disease progression Hashimoto 's thyroiditis .</detailed_description>
	<mesh_term>Thyroiditis</mesh_term>
	<mesh_term>Hashimoto Disease</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Hashimoto 's thyroiditis Euthyroid state ( free T4 thyroidstimulating hormone level within normal limit ) Never receive immunomodulators immunosuppressant Planned pregnant already pregnant woman Renal insufficiency Hepatic insufficiency Anemia Agranulocytosis Thrombocytopenia Glucose6phosphate dehydrogenase deficiency Porphyria cutaneous tarda Allergy 4aminoquinolone</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>